Antimicrobial resistance (AMR)
Antimicrobial resistance (AMR) is an increasing public health challenge in Ethiopia, where a high burden of infectious diseases coincides with limited diagnostic capacity and restricted access to effective antimicrobials. Multidrug-resistant organisms are frequently detected in clinical settings, complicating patient management and reducing treatment options.
GHIDA’s AMR activities focus on characterizing local resistance patterns, strengthening microbiological diagnostics, and supporting antimicrobial stewardship (AMS). Current projects investigate resistant pathogens in hospital-acquired infections, urinary tract infections, neonatal sepsis, and environmental reservoirs, employing a One Health approach.
In collaboration with regional and international partners, GHIDA is implementing advanced diagnostic tools, including molecular resistance testing and next-generation sequencing (NGS). These approaches, combined with improved culture-based diagnostics and digital reporting systems, aim to support more informed clinical decision-making.
Through laboratory strengthening, capacity building, and the introduction of innovative diagnostics, GHIDA contributes to improved management of resistant infections and the development of sustainable AMR control strategies in Ethiopia.